<p>Abbreviations: BP, blood pressure; SBP, systolic blood pressure; DBP, diastolic blood pressure; HTN, hypertension; HDL, high density lipoprotein; GFR, glomerular filtration rate; NA, not available.</p>*<p>Weighted number.</p>†<p>The unweighted number (for means) or numerator (for prevalences) corresponding with each variable category.</p>‡<p>In order to account for a change in NHANES race/ethnicity definitions in 2005–2010, we placed Hispanic in the “Other” to be consistent with NHANES 1988–2004.</p>§<p>Defined as >6.0 mg/dL (360 µmol/L) in women and >7.0 mg/dL (420 µmol/L) in men.</p>∥<p>Gout medications included allopurinol, probenecid, colchicine, sulfinpyrazone, alloxanthine.</p
Data from the National Vital Statistics System\u2022 In survey period 2017\u20132018, the prevalence...
Recent blood pressure trends reflect progress in hypertension control, but prevalent drug therapy pr...
Detection of hypertension and blood pressure control are critically important for reducing the risk ...
OBJECTIVES: To describe hypertension trends in U.S. adults aged 60 and older using National Health a...
Data from the National Health and Nutrition Examination Surveys. In 2005-2006, 29% of all U.S. adult...
The 2017 American College of Cardiology/American Heart Association (ACC/AHA) Guideline for the Preve...
Results from the National Health and Nutrition Examination Survey (NHANES) indicate that hypertensio...
<p>No information: Income (n = 70); Race (n = 184) (excluded from the total).</p><p>Longitudinal Stu...
Background This study aims to compare the prevalence of hypertension (HTN) and controlled hypertensi...
Isolated systolic hypertension (ISH) predominates hemodynamic hypertension subtypes and becomes a si...
Population-weighted characteristics of the eligible sample and the full sample of U.S. adults ≥ 20 y...
<p>Age-standardized prevalence of total hypertension by sex and race among adults 30 years and older...
The prevalence, awareness, treatment, and control of hypertension in the United States are analyzed ...
ObjectivesThis study sought to characterize the prevalence of metabolic syndrome (MetS), its 5 compo...
Hypertension or substantially elevated blood pres\uadsure is one of the more prevalent chronic condi...
Data from the National Vital Statistics System\u2022 In survey period 2017\u20132018, the prevalence...
Recent blood pressure trends reflect progress in hypertension control, but prevalent drug therapy pr...
Detection of hypertension and blood pressure control are critically important for reducing the risk ...
OBJECTIVES: To describe hypertension trends in U.S. adults aged 60 and older using National Health a...
Data from the National Health and Nutrition Examination Surveys. In 2005-2006, 29% of all U.S. adult...
The 2017 American College of Cardiology/American Heart Association (ACC/AHA) Guideline for the Preve...
Results from the National Health and Nutrition Examination Survey (NHANES) indicate that hypertensio...
<p>No information: Income (n = 70); Race (n = 184) (excluded from the total).</p><p>Longitudinal Stu...
Background This study aims to compare the prevalence of hypertension (HTN) and controlled hypertensi...
Isolated systolic hypertension (ISH) predominates hemodynamic hypertension subtypes and becomes a si...
Population-weighted characteristics of the eligible sample and the full sample of U.S. adults ≥ 20 y...
<p>Age-standardized prevalence of total hypertension by sex and race among adults 30 years and older...
The prevalence, awareness, treatment, and control of hypertension in the United States are analyzed ...
ObjectivesThis study sought to characterize the prevalence of metabolic syndrome (MetS), its 5 compo...
Hypertension or substantially elevated blood pres\uadsure is one of the more prevalent chronic condi...
Data from the National Vital Statistics System\u2022 In survey period 2017\u20132018, the prevalence...
Recent blood pressure trends reflect progress in hypertension control, but prevalent drug therapy pr...
Detection of hypertension and blood pressure control are critically important for reducing the risk ...